Site search

Clear filter
2880 results for '' found
A Phase 1b Study Evaluating the Safety and Tolerability of CLB-4000 with or without Peg-IFNa-2a in Subjects with Chronic Hepatitis B (ACTRN12625000204448)
A Phase 1b Study Evaluating the Safety and Tolerability of CLB-4000 with or without Peg-IFNa-2a in Subjects with Chronic Hepatitis B (ACTRN12625000204448)
/
A Phase 1-1b Study to Evaluate the Safety, Efficacy and Dosimetry of [225Ac]Ac-A9-3408 in Subjects with Unresectable or Metastatic Melanoma Expressing MC1R
A Phase 1-1b Study to Evaluate the Safety, Efficacy and Dosimetry of [225Ac]Ac-A9-3408 in Subjects with Unresectable or Metastatic Melanoma Expressing MC1R
/
Antigen Triggers in Inflammatory Skin-disease (Trial Not Registered)
Antigen Triggers in Inflammatory Skin-disease (Trial Not Registered)
/
STRIKE: Silicosis Treatment with Infliximab – A Key Evaluation (ACTRN12625000499482)
STRIKE: Silicosis Treatment with Infliximab – A Key Evaluation (ACTRN12625000499482)
/
Portico Re-sheathable Transcatheter Aortic Valve System US IDE Trial (PORTICO)
Portico Re-sheathable Transcatheter Aortic Valve System US IDE Trial (PORTICO)
/
Master Screening Study to Determine Individuals With Potential Trial Eligibility for Alzheimer’s Disease Studies as Assessed by Biomarker Status and Cognition (NCT07177352)
/
Replenishing Human Myocardial NAD+ to Rescue HFpEF – The pEFNAD Study (Trial Not Registered)
Replenishing Human Myocardial NAD+ to Rescue HFpEF – The pEFNAD Study (Trial Not Registered)
/
Personalised Exercise Rehabilitation FOR people with multimorbidity (ACTRN12624001191583)
Personalised Exercise Rehabilitation FOR people with multimorbidity (ACTRN12624001191583)
/
A Phase 2b, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Tulisokibart in Participants with Moderate to Severe Hidradenitis Suppurativa (NCT06956235)
/
Supplementing with IL-2 to Verifiably eRadicate Radiological Progression (NCT07063875)
Supplementing with IL-2 to Verifiably eRadicate Radiological Progression (NCT07063875)
/
14 15 16 17 18